Adagene Inc. (ADAG) Financials
ADAG Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-06-30 | 135.3 million | 52.5 million |
2023-03-31 | 152.4 million | 69.3 million |
2022-12-31 | 152.4 million | 69.3 million |
2022-09-30 | 152.4 million | 69.3 million |
ADAG Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-06-30 | 2.0 million | 2.0 million |
2023-03-31 | 15.7 million | 2.4 million |
2022-12-31 | ? | ? |
2022-09-30 | 2.4 million | 2.4 million |
ADAG Net Income
No data available :(
ADAG Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-06-30 | 128.8 million | - | 300290 |
2023-03-31 | 143.8 million | - | - |
2022-12-31 | 143.8 million | - | 205817 |
2022-09-30 | 143.8 million | - | - |
ADAG Shares Outstanding
ADAG Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-06-30 | - | 21.3 million | 2.2 million | 2.2 million |
2023-03-31 | 787528 | 36.0 million | 2.5 million | 2.5 million |
2022-12-31 | - | - | - | - |
2022-09-30 | - | 18.1 million | 2.5 million | 17364 |
ADAG Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-06-30 | 17.3 million | 8.6 million |
2023-03-31 | 5.3 million | 2.7 million |
2022-12-31 | - | - |
2022-09-30 | 2.7 million | - |
ADAG
Price: $2.41
52 week price:
Earnings Per Share: -0.86 USD
P/E Ratio: -4.13
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 47600
Market Capitalization: 125.7 million